Presented by
NSW Going Global Series
Sessions for NSW Going Global program participants, exporting to international markets around the world.
Hosted By
17 Went
Private Event
Going Global - BIO 2025 - Capital Raising in the US
Registration
Past Event
About Event
This is part of the Investment NSW Going Global Program - a series of sessions in the lead up to BIO 2025 to provide insight and learnings on a variety of topics for Australian companies targeting the US market and attending BIO 2025 in Boston, MA.
This session will focus on Capital raising in the US, where we will hear from investors and founders that have successfully raised US capital on the current market, the differences between the US and Australia, and advice and tips on your approach to raising your next round.
Speakers
Daniel Getts - Founder and CEO - Myeloid Therapeutics
Amir Zalcenstein - Managing Director - Synthesis BioVentures
Presented by
NSW Going Global Series
Sessions for NSW Going Global program participants, exporting to international markets around the world.
Hosted By
17 Went